On Feb. 23, the company announced that it was changing its name and ticker symbol. TransEnterix changed its official name to Asensus Surgical on its website and other such official communications. Additionally, on March 5, Asensus’ ticker symbol changed from TRXC stock to ASXC stock.
Similarly Why did TransEnterix change their name? Research Triangle Park, N.C.-based Asensus Surgical said in a news release that its name change represents its broader vision of shaping the future of surgery by integrating computer vision and machine learning with surgical robotics.
Did TRXC reverse split? TransEnterix (NYSE:TRXC) announced that it will effect a 13-to-1 reverse split of the company’s common stock. … The company added that no fractional shares are issued in connection with the split, as it will round up any fractional shares resulting from it to the nearest whole share.
Additionally, Who owns Asensus Surgical?
Who owns ASENSUS SURGICAL? ASENSUS SURGICAL (NYSEMKT: ASXC) is owned by 28.61% institutional shareholders, 67.15% ASENSUS SURGICAL insiders, and 4.24% retail investors. Stepstone Group Holdings LLC is the largest individual ASENSUS SURGICAL shareholder, owning 29.19M shares representing 12.35% of the company.
What does ascensus surgical do?
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy.
What is TRXC stock price? Key Turning Points
| 52-Week High | 6.95 |
|---|---|
| Last Price | 4.08 |
| Fibonacci 50% | 3.62 |
| Fibonacci 38.2% | 2.83 |
| 52-Week Low | 0.28 |
• 4 mars 2021
What is TRXC new ticker symbol? Effective today, Friday March 5, 2021 , the Company’s stock will trade on the NYSE American under its new ticker symbol ASXC, and name, Asensus Surgical, Inc. The previous ticker symbol was “TRXC,” and the previous name was “TransEnterix, Inc.”
What is TRXC? Asensus Surgical , Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided…
Is Asensus surgical a buy?
And if that wasn’t enough, Asensus Surgical is so cheaply priced that investors indirectly get back more than 60% of their investment via the company’s aforementioned $147.9 million cash and investments balance. These factors make the stock appear to be a buy for long-term growth investors.
How much does a Senhance robot cost? While the upfront cost of its Surgical Senhance System is about $1.5 million to $2 million, the robotic device can reduce costs of medical operations by about two-thirds, says Chief Executive Officer Todd Pope, who was named among the nation’s 50 most influential health-care executives by Time magazine in October.
Is Asensus surgical?
Asensus Surgical’s technology platform, Senhance® Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning.
Will TRXC stock go up? Ladenburg Thalmann does not see either upside or downside right now giving TRXC « » on their last update on Jan 20, 2021. The price target was changed from 3.47 to 0.57.
…
Predicted Opening Price for TransEnterix, Inc of Wednesday, April 6, 2022.
| Fair opening price April 6, 2022 | Current price |
|---|---|
| $0.70 | $0.70 (Undervalued) |
What happens to TRXC stock?
TRXC stock will begin trading under the new name and ticker ASXC on March 5, 2021. The company said, “the name change [to Asensus Surgical] reflects the company’s broader vision of shaping the future of surgery by integrating computer vision and machine learning with surgical robotics.”
How is TRXC stock doing?
Below are the latest news stories about Transenterix Inc that investors may wish to consider to help them evaluate TRXC as an investment opportunity.
…
TRXC Price Returns.
| YTD | N/A |
|---|---|
| 2020 | -57.48% |
| 2019 | -95.00% |
| 2018 | 17.10% |
| 2017 | 48.46% |
Did TransEnterix change its name? Asensus Surgical (NYSE:ASXC) announced today that it formally completed its name and stock ticker change from TransEnterix (NYSE:TRXC). Research Park Triangle, N.C.-based Asensus announced last month that the company would change its name from TransEnterix to Asensus Surgical and introduce a new surgery category.
What is Tronclassic? TRONCLASSIC (TRXC) is a cryptocurrency and operates on the Ethereum platform. TRONCLASSIC has a current supply of 1,000,000,000,000 with 0 in circulation.
Is TRXC a good stock to buy now?
During the day the stock fluctuated 9.41% from a day low at $0.73 to a day high of $0.80.
…
Predicted Opening Price for TransEnterix, Inc of Tuesday, February 15, 2022.
| Fair opening price February 15, 2022 | Current price |
|---|---|
| $0.75 | $0.74 (Undervalued) |
What is NAKD stock? Cenntro Electric Group Ltd (NAKD)
What is Senhance system?
The Senhance Surgical Robotic System is a new robotically-assisted surgical device (RASD) that can help facilitate minimally invasive surgery. This robotic platform allows surgeons to sit at a console unit with 3D high-definition view and remotely control three separate robotic arms.
What is a lap procedure? Laparoscopy is a type of surgical procedure that allows a surgeon to access the inside of the abdomen (tummy) and pelvis without having to make large incisions in the skin. This procedure is also known as keyhole surgery or minimally invasive surgery.
